SCHEMBL1098799

SCHEMBL1098799

CCN(c1sc2ccccc2c1Br)S(=O)(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1R P00736 2/20 0.44
PRSS1 P07477 2/20 0.44
ESR1 P03372 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NR1I2 O75469 2/20 0.42
HSD11B1 P28845 2/20 0.41
KEAP1 Q14145 2/20 0.40
NFE2L2 Q16236 2/20 0.40
RORC P51449 2/20 0.40
RORA P35398 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
RORB Q92753 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
TRPM8 Q7Z2W7 3/20 0.39
PHOSPHO1 Q8TCT1 1/20 0.38
CNR1 P21554 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1099776 0.89 TRPM8 (0.52) ESR1KMT2ATRPM8
SCHEMBL1098503 0.87 TDP1 (0.49) C1RPRSS1ESR1KMT2ANR1I2
SCHEMBL1097407 0.86 KEAP1 (0.37) C1RPRSS1MAPK1HSD11B1KEAP1
SCHEMBL1098790 0.85 TRPM8 (0.47) ESR1TSHRKMT2ANR1I2HSD11B1
SCHEMBL1098270 0.85 ALOX5 (0.44) C1RPRSS1ESR1NR1I2KEAP1
SCHEMBL1099122 0.85 TRPM8 (0.37) C1RPRSS1ESR1HSD11B1KEAP1
SCHEMBL1099972 0.84 TRPM8 (0.37) C1RPRSS1ESR1HSD11B1KEAP1
SCHEMBL1099417 0.84 NR1I2 (0.47) TSHRMAPK1NR1I2HSD11B1KEAP1
SCHEMBL1098844 0.83 NR1I2 (0.44) ESR1KMT2ANR1I2KEAP1NFE2L2
SCHEMBL1099996 0.83 KEAP1 (0.37) KMT2AHSD11B1KEAP1NFE2L2TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 C1R 3178/4885PRSS1 712/4885ESR1 1247/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 C1R 3178/4885PRSS1 712/4885ESR1 1247/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 C1R 3178/4885PRSS1 712/4885ESR1 1247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.